HIV/AIDS Clinical Trials in Los Angeles

Showing 141-160 of 290 trials

Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

NCT01828593

The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.

HIV-associated Enteropathy

Entera Health, Inc103 participantsStarted Apr 2013

Los Angeles, California, United States • Sacramento, California, United States • San Francisco, California, United States +7 more locations

TERMINATEDPHASE2< 1 mile

GW873140 In Combination With Combivir In HIV Infected Subjects

NCT00104429

This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Combivir in HIV infected, untreated subjects.

Infection, Human Immunodeficiency Virus IHIV Infection

ViiV Healthcare125 participantsStarted Jan 2005

Bakersfield, California, United States • Beverly Hills, California, United States • Los Angeles, California, United States +48 more locations

Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

GW873140 In Combination With Combivir In HIV Infected Subjects

HIV/AIDS Trials in Other Cities

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

Integrated Treatment of Marijuana Abuse for HIV+ Youth

Engaging Care for HIV-infected Adolescent Females.

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

C2P Mobilization Intervention (Pilot)

HIV Treatment-Readiness Measure (HTRM) Validation

CDC-ATN Linkage Evaluation

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Linkage to Care - Part II

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Treatment De-Intensification and Residual HIV-1 in Youth

Immunologic Memory (Supp. of ATN 024)

Factors Affecting PrEP Adherence

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

PRO 140 for Human Immunodeficiency Virus Infection

Other Conditions in Los Angeles